Funding is available to support community based health research studies. Awards up to a maximum of $20K will be allocated based on a competitive application process. Eligible applications must be led by an academic investigator (AI) who partners with a community investigator (CI). Each applicant must have a designated mentor. Applications are to be submitted electronically through the ACCEL website, and are due September 15, 2014. Click here for application details.
In a key component of the ACCEL grant for clinical and translational research initiatives, Christiana Care is working to conduct research that is meaningful to Delawareans, and ultimately will improve health in the First State. This was the focus of the Delaware CTR-ACCEL conference on community engagement on May 12 at the Chase Center on the Riverfront in Wilmington. Attended by more than 200 researchers, health care professionals and community leaders, the conference focused on how to develop research initiatives that will translate from hypothesis to effective treatment and better health care.
A big boost to medical research in Delaware.
WDEL's Mellany Armstrong reports. "We are really going to work together to try to tackle some of the most onerous problems, healthcare problems, that affect all of us."
The University of Delaware and partner institutions have gotten $25 million from the National Institutes of Health and Delaware to accelerate medical research. Stuart Binder-MacLeod is principal investigator on the ACCEL program at UD. "We have young investigators with great ideas and if they could only get a little bit of pilot data, they really will be able to grow that idea into something bigger," he said.
Delaware CTR-ACCEL has awarded pilot grants to two Christiana Care Health System researchers to further their studies in advancing patient care through a federally funded, multi-site grant program supporting clinical and translational research. Ursula Guillen, M.D., of Christiana Care Neonatal Associates, received $84,000 and Senior Clinical Scientist Jennifer Sims-Mourtada, Ph.D., of the Helen F. Graham Cancer Center & Research Institute, received $89,000.
With her grant, Dr. Sims-Mourtada will further her research into new treatment options for patients with triple negative breast cancer. Her mentor is Daniel C. Flynn, Ph.D., of the University of Delaware....
UD-led team awarded $25 million to support research infrastructure development
9:41 a.m., Oct. 2, 2013--The University of Delaware, along with partners Christiana Care Health System, Nemours/A.I. duPont Hospital for Children (Nemours), and the Medical University of South Carolina, has received $25 million to support the growth of clinical and translational research over the next five years. The total includes almost $20 million from the National Institutes of Health (NIH) and $5 million from the state of Delaware, with an additional $3.3 million in matching funds provided by the four participating institutions.
The new program, called Delaware-CTR ACCEL, will be led by Stuart Binder-Macleod, associate vice provost for clinical and translational research at UD. The program executive committee includes members from each of the participating institutions: Thomas Buchanan, director of the Delaware Rehabilitation Institute at UD; William S. Weintraub, chair of cardiology at Christiana Care; Julia S. Barthold, associate chief of urology at Nemours; and Steven Kautz, professor and chair of the Department of Health Sciences and Research at the Medical University of South Carolina. Buchanan is also the program coordinator for the project.
Event launches program to support research infrastructure development in Delaware
4:21 p.m., Feb. 10, 2014--More than 100 people representing all sectors of the health sciences community turned out on Friday, Feb. 7, at the University of Delaware’s Science, Technology and Advanced Research (STAR) Campus for the launch of a new program that has the potential to write the next chapter of clinical and translational medicine in Delaware.
The event was held to celebrate a $20-million Clinical and Translational Research (CTR) award from the National Institutes of Health aimed at fostering productive partnerships between basic and clinical scientists. The state of Delaware is supporting the program, known as ACCEL, with an additional $5 million.
How can health professionals help patients live better?
It's a question that seems deceptively easy to answer. Sure, doctors can cite grim statistics about the life-altering effects of heart disease and obesity. They can talk about making healthy choices. They can gently nag, relying on their white-coat authority. And increasingly, they can pull out a prescription pad.
But all of that might not translate into better patient outcomes.
The federal money will help researchers learn how to improve health care infrastructure and patient-doctor interaction.
The University of Delaware will join with Christiana Care, Nemours/A.I. duPont Hospital for Children and the Medical University of South Carolina for the ACCEL program.
The money will be used to expand clinical and translational research. Translational research is the study of how to put clinical research into action. "The purpose of this grant is to build research infrastructure in Delaware," said Dr. William Weintraub is the director of Christiana Care's Center for Outcomes Research. He's the co-principal investigator for clinical and translational research at Christiana Care.
There are a number of different areas of research being funded including community engagement work which is being done at Christiana Care. "That's really the central core of the whole CTR is about engaging the community, because the idea is to build research infrastructure that allows us ultimately to improve care and improve health..."
Delaware-CTR ACCEL program meeting features talks, networking
12:45 p.m., March 11, 2014--After Megan Wenner finished giving her research talk, a buzz ran through the room. The new University of Delaware assistant professor of kinesiology and applied physiology is studying the link between female hormones and cardiovascular function and others were eager to speak with her.
Those “others” were attendees of the first of meetings the Delaware-CTR ACCEL plans to hold annually. The gathering was held March 9-11 at the Mendenhall Inn in Chadds Ford, Pa., and about 150 people were present Monday for a full day of talks, networking and workshops.
CTR stands for Clinical and Translational Research and ACCEL refers to the aim of the new program, which is to advance biomedical research in Delaware from the lab to the bedside...
The National Institutes of Health (NIH) and the State of Delaware announced Friday at the University of Delaware’s STAR campus that they’re awarding Delaware’s new ACCEL program $25 million to fuel new medical research in the area.
NIH is giving $20 million to ACCEL from the NIH’s Institutional Development Award or IDeA program that helps states that are under-represented in NIH funding. The money will provide ACCEL seed funding for new research initiatives in clinical and translational medicine with the goal of putting research to practical use.